Aspira Pathlab & Diagnostics Ltd.

ASPIRA

₹61.8

3.0% (1.8)

Market Cap

₹64 Cr.

P/E

26.52

Key Ratios

Edit Ratio's

Market cap

64.00 Cr

26.52

Prom Holding

18.39 %

ROE (%)

16.62

ROCE (%)

16.04

Div Yield (%)

Sales

24.24 Cr

OPM (%)

11.77 %

Debt to Equity

0.10

Edit Ratio's

About

Aspira Pathlab & Diagnostics Limited is solely engaged in the business of running laboratories… Read more

Low

52W Range

High

107

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

8 Yes

Positive for this company

3 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
ROE

Financial leverage has increased roe over 10 years
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Share price

Share price has increased over last 10 years but more due to rerating
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Aspira Pathlab & Diagnostics Ltd. Business

What does Aspira Pathlab&Diagn do?

Aspira Pathlab & Diagnostics Limited specializes in operating laboratories for a wide range of pathological investigations across multiple branches of healthcare.

Who are the competitors of Aspira Pathlab&Diagn?

Aspira Pathlab&Diagn major competitors are Invicta Diagnostic, Modern Diagnostic, Nephro Care India, Chandan Healthcare, Krsnaa Diagnostics, Vimta Labs, Thyrocare Tech..
Market Cap of Aspira Pathlab&Diagn is ₹62 Crs.
While the median market cap of its peers are ₹670 Crs.

Is Aspira Pathlab&Diagn financially stable compared to its competitors?

Aspira Pathlab&Diagn seems to be less financially stable compared to its competitors.
Altman Z score of Aspira Pathlab&Diagn is 8.81 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Aspira Pathlab & Diagnostics Ltd.

Aspira Pathlab & Diagnostics Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

8 Yes

3 Neutral

6 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Other Income

Pledge

Revenue Recognition

Promoter Holding

Depreciation Effect

Retail Holding

Price & Performance

Capex vs ROCE

Working Capital

Debt

Sales Growth

ROE

Balance Sheet Strength

Current vs Historic Valuation

Share price

Margin Stability

ROCE Strength

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Peer Comparison

FAQs on Aspira Pathlab & Diagnostics Ltd. Business

What does Aspira Pathlab&Diagn do?

Who are the competitors of Aspira Pathlab&Diagn?

Is Aspira Pathlab&Diagn financially stable compared to its competitors?

Company Filing

Discussions & Analysis

SIGN UP FOR FREE